Alzheimer disease and other dementias (ADOD) have a substantial impact on the prevalence and costs of certain comorbid conditions compared with matched beneficiaries without ADOD.
Patricia R. Salber, MD, MBA
Advertisement
Articles by Patricia R. Salber, MD, MBA
Advertisement
Latest Updated Articles
- Screening for Colorectal Cancer: The Business Case
Published: June 1st 2002 | Updated:
- How Managed Care Organizations Contribute to Improved Diabetes Outcomes
Published: January 15th 2008 | Updated:
- Impact of Dementia on Costs of Modifiable Comorbid Conditions
Published: November 8th 2018 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Tirzepatide Plus Hormone Therapy Boosts Weight Loss in Menopause: Regina Castaneda, MD
2
FDA Approves Elinzanetant, a Hormone-Free Option for Hot Flashes in Menopause
3
GLP-1 Receptor Agonists May Improve Rheumatoid Arthritis Symptoms
4
Elinzanetant Shows Strong 52-Week Safety for Vasomotor Symptoms: James Simon, MD
5
